We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$5.55B
AUM Growth
+$896M
Cap. Flow
+$296M
Cap. Flow %
5.33%
Top 10 Hldgs %
41.26%
Holding
123
New
43
Increased
33
Reduced
14
Closed
29

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$135M
2
FISV
Fiserv Inc
FISV
+$129M
3
EL icon
Estee Lauder
EL
+$128M
4
AMZN icon
Amazon
AMZN
+$101M
5
MDT icon
Medtronic
MDT
+$81.8M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$104M
2
J icon
Jacobs Solutions
J
+$103M
3
MCK icon
McKesson
MCK
+$89M
4
CNC icon
Centene
CNC
+$87.9M
5
META icon
Meta Platforms (Facebook)
META
+$71M

Sector Composition

Rank Sector Weight
1 Technology 23.21%
2 Consumer Discretionary 19.67%
3 Healthcare 17.72%
4 Industrials 15.31%
5 Communication Services 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
76
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$2.47M 0.04%
45,000
– –
EPIX
77
DELISTED
ESSA Pharma
EPIX
$2.06M 0.04%
+298,800
New +$2.03M
WPF.WS
78
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
$1.96M 0.04%
+868,799
New +$1.84M
EIGR
79
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.62M 0.03%
6,647
– –
CERE
80
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.57M 0.03%
+150,000
New +$1.58M
JWS.WS
81
DELISTED
Jaws Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary
JWS.WS
$1.43M 0.03%
+674,566
New +$1.45M
CALC icon
82
CalciMedica
CALC
$10.9M
$1.39M 0.03%
+7,836
New +$1.63M
KLRS
83
Kalaris Therapeutics
KLRS
$96.8M
$1.07M 0.02%
+1,696
New +$1.16M
TNGX icon
84
Tango Therapeutics
TNGX
$4.41B
$1.04M 0.02%
+100,000
New +$1.02M
OTIC
85
DELISTED
Otonomy, Inc.
OTIC
$1.01M 0.02%
+250,000
New +$942K
ORGNW
86
DELISTED
Origin Materials Inc Warrants
ORGNW
$979K 0.02%
+607,833
New +$968K
PSTX
87
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$710K 0.01%
+80,000
New +$910K
TREB.WS
88
DELISTED
Trebia Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
TREB.WS
$658K 0.01%
+438,666
New +$664K
OBIO icon
89
Orchestra BioMed
OBIO
$254M
$550K 0.01%
+50,000
New +$561K
BLU
90
DELISTED
BELLUS Health Inc.
BLU
$547K 0.01%
240,900
– –
HRMY icon
91
Harmony Biosciences
HRMY
$2.24B
$424K 0.01%
+12,500
New +$456K
ARYBW
92
DELISTED
ARYA Sciences Acquisition Corp II Warrant
ARYBW
$91K ﹤0.01%
+50,000
New +$99.4K
ADAP
93
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-268,900
Closed -$2.69M
ADCT icon
94
ADC Therapeutics
ADCT
$144M
– –
-175,090
Closed -$8.2M
BAX icon
95
Baxter International
BAX
$14.2B
– –
-1,204,204
Closed -$104M
BSX icon
96
Boston Scientific
BSX
$71.5B
– –
-455,000
Closed -$16M
CNC icon
97
Centene
CNC
$32.5B
– –
-1,382,640
Closed -$87.9M
CSGP icon
98
CoStar Group
CSGP
$12.3B
– –
-459,000
Closed -$32.6M
DGX icon
99
Quest Diagnostics
DGX
$26.3B
– –
-357,835
Closed -$40.8M
DHI icon
100
D.R. Horton
DHI
$42.3B
– –
-1,171,548
Closed -$65M
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Suvretta Capital Management held 123 positions worth $5.55B, up 19% from $4.65B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Suvretta Capital Management deployed $296M of net new capital in Q3 2020, opening 43 new positions and adding to 33 existing holdings. Its largest new stake was Air Products & Chemicals: 470,440 shares worth $140M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $71M trimmed.

  • Suvretta Capital Management's largest Q3 2020 buy was Air Products & Chemicals: 470,440 shares worth $140M.
  • Suvretta Capital Management added most to Amazon in Q3 2020, an estimated $101M increase.
  • Suvretta Capital Management's biggest Q3 2020 reduction was Meta Platforms (Facebook), cutting an estimated $71M.
  • Suvretta Capital Management fully exited Baxter International in Q3 2020, selling an estimated $104M.
  • Suvretta Capital Management's ten largest holdings make up 41% of its $5.55B portfolio in Q3 2020.
  • Suvretta Capital Management opened 43 new positions and closed 29 in Q3 2020.
  • Suvretta Capital Management's portfolio value rose 19% quarter-over-quarter to $5.55B.

Based on Suvretta Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.